Halozyme Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.

CEO

Helen I. Torley

CEOHelen I. Torley

Employees

350

Employees350

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

350

Employees350

HALO Key Statistics

Market cap

7.48B

Market cap7.48B

Price-Earnings ratio

17.27

Price-Earnings ratio17.27

Dividend yield

—

Dividend yield—

Average volume

1.53M

Average volume1.53M

High today

$60.88

High today$60.88

Low today

$58.49

Low today$58.49

Open price

$58.89

Open price$58.89

Volume

980.58K

Volume980.58K

52 Week high

$66.00

52 Week high$66.00

52 Week low

$37.97

52 Week low$37.97

HALO News

Seeking Alpha 1d

Halozyme files patent lawsuit against Merck over injectable Keytruda

Halozyme Therapeutics (NASDAQ:HALO) on Thursday announced a lawsuit against Merck (NYSE:MRK) over allegations that an injectable version of the New Jersey-based...

Simply Wall St 6d

Halozyme Therapeutics Has A Rock Solid Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankrupt...

Analyst ratings

56%

of 9 ratings

Buy

55.6%

Hold

44.4%

Sell